Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Decreases By 86.6%

Basilea Pharmaceutica AG (OTCMKTS:BPMUF) saw a significant decrease in short interest during the month of March. As of March 15th, there was short interest totalling 2,100 shares, a decrease of 86.6% from the February 28th total of 15,700 shares. Based on an average daily volume of 100 shares, the short-interest ratio is currently 21.0 days. Approximately 0.0% of the company’s stock are sold short.

Basilea Pharmaceutica Price Performance

BPMUF stock remained flat at $54.00 during midday trading on Friday. The company has a fifty day simple moving average of $52.92 and a 200 day simple moving average of $52.60. Basilea Pharmaceutica has a one year low of $38.60 and a one year high of $54.00. The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.